Pieris Pharmaceuticals (NASDAQ: PIRS) is a clinical stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in a unique and transformative way. 

Pharmaceutical

Pieris Pharmaceuticals

Pieris Pharmaceuticals' headquarters in Boston, MA, United States

Stephen S. Yoder

Frank Vollmering

Shane Olwill

Tom Bures

James Geraghty

Michael Richman

Christopher Kiritsy

Ann Barbier

Peter Kiener

Maya R. Said

Padmanee Sharma

Vijay Kuchroo

Matthew L. Sherman

Michael Curran

Dario Vignali

Ian Adcock

Bruce Levy

E. John Werry

David Schwartz

Sally Wenzel

Peter Barnes

Gary Anderson

Oliver Eickelberg

Fan Chung

Description

People (1)

Stephen S. Yoder

Jobs